Topic

Venture Capital

12
Jan
2020

EQRx Taps Zeitgeist, Raises $200m For Innovative Drugs at Aggressive Low Prices

Alexis Borisy is smart. As in high IQ. But there’s more to biopharma than that. “As my grandmother used to say, ‘You can be smart, smart, smart…but dumb,’” Borisy said. Some old wisdom is part of what’s driving Cambridge, Mass.-based EQRx. The company, started by the former Third Rock Ventures partner and backed by $200 million of “smart money” in...
Read More
20
Dec
2018

Relay Therapeutics Hauls in $400M to Push Frontier in Computational Drug Discovery

Computers have been overhyped as tools of drug discovery for 15-20 years. But things have started turning in the right direction the past couple years, judging from recent bets by a few perspicacious investors. The latest example: Relay Therapeutics. Cambridge, Mass.-based Relay is announcing today it has raised a $400 million Series C financing heavy on private-public crossover investors. SoftBank...
Read More
3
Jan
2018

Finding a Path in Biotech VC: The Long Run Podcast With Bob More

Today’s guest on The Long Run is Bob More. He’s a managing director with Alta Partners, a healthcare-focused venture capital firm. More got started as a young pup in biotech in the 1980s. He moved around between big companies and small companies. He advanced to a couple well-known healthcare VC firms – Domain Associates and Frazier Healthcare Partners. Before joining...
Read More